Healthcare Thought Leader & Visiting Research Fellow at the Paragon Health Institute, Kev Coleman, highlights key considerations to watch for AI healthcare policy under a Trump 2.0 administration. To read more of Kev's research, please visit here. Stay tuned for the Paragon consolidated AI page, and Kev's paper with Michael Penina from Duke University that will be announced at a later time. For further insights, read Kev's paper "Healthcare AI Regulation: Guidelines for Maintaining Pu...
All content for The AI Healthcare Podcast is the property of Dylan Reid and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Healthcare Thought Leader & Visiting Research Fellow at the Paragon Health Institute, Kev Coleman, highlights key considerations to watch for AI healthcare policy under a Trump 2.0 administration. To read more of Kev's research, please visit here. Stay tuned for the Paragon consolidated AI page, and Kev's paper with Michael Penina from Duke University that will be announced at a later time. For further insights, read Kev's paper "Healthcare AI Regulation: Guidelines for Maintaining Pu...
Tatyana Tavella: AI Expert and Scientific Researcher of Hematology at Institut Cochin
The AI Healthcare Podcast
39 minutes
8 months ago
Tatyana Tavella: AI Expert and Scientific Researcher of Hematology at Institut Cochin
How can hematology help us understand the application of AI to the drug discovery process? AI Expert and Scientific Researcher of Hematology at Institut Cochin, Tatayana Tavella teaches us how. To connect with Tatyana, visit her Linkedin here. To read more about Tatayna's research, visit her Google Scholar page here. Key Takeaways: 1. Tatyana's pharmacology internship at the National Institutes of Health is what drove her to do a PhD. 2. The use of computational tools in the drug d...
The AI Healthcare Podcast
Healthcare Thought Leader & Visiting Research Fellow at the Paragon Health Institute, Kev Coleman, highlights key considerations to watch for AI healthcare policy under a Trump 2.0 administration. To read more of Kev's research, please visit here. Stay tuned for the Paragon consolidated AI page, and Kev's paper with Michael Penina from Duke University that will be announced at a later time. For further insights, read Kev's paper "Healthcare AI Regulation: Guidelines for Maintaining Pu...
